A propensity to compare oneself to others increases breast cancer survivors’ social anxiety regarding body image; however, having a high self-regard can mitigate this effect.

Researchers evaluated the patient-specific factors that were associated with a greater risk of advanced disease at the time of melanoma diagnosis.

The study results "signal unmet needs and potentially undertreated pain in patients with cancer,” researchers wrote.

The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single agent Imfinzi as adjuvant ...

DB-1305/BNT325 was generally well tolerated and exhibited “very encouraging and durable antitumor activity in ovarian cancer patients,” said Maria Rubinstein, MD.

Largest number of cancers was projected to result from abdomen and pelvic CT in adults, reflecting 37 percent of those 103,000 cancers.

Repeat biopsies in patients with TNBC may detect changes in HER2 status and allow more patients to gain access to T-DXd, data suggest.

A vomiting-free ward protocol significantly reduced the effects of nausea and vomiting on QOL, anxiety, and depression, in patients with gynecologic cancers receiving chemotherapy.

Our data clearly show that it is feasible and safe to implement stepwise acceleration of nivolumab and pembrolizumab administration to a 10-minute infusion time,” the researchers wrote.

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Medical staff and patients with CRC reported that intermittent symptom management did not provide sufficient support to patients at home.

Until prospective data are available, researchers recommend that patients with ER-low breast cancer “should be counseled regarding the potential benefit” of adjuvant endocrine therapy.